Paragon Care Full Year 2025 Earnings: Misses Expectations

August 31, 2025

Paragon Care (ASX:PGC) Full Year 2025 Results

Key Financial Results

Revenue: AU$3.61b (up 22% from FY 2024).
Net income: AU$20.6m (up 146% from FY 2024).
Profit margin: 0.6% (up from 0.3% in FY 2024). The increase in margin was driven by higher revenue.
EPS: AU$0.012 (up from AU$0.009 in FY 2024).

Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit.

revenue-and-expenses-breakdown — ASX:PGC Revenue and Expenses Breakdown August 31st 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Paragon Care Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 3.9%. Earnings per share (EPS) also missed analyst estimates by 31%.

The primary driver behind last 12 months revenue was the ANZ segment contributing a total revenue of AU$3.51b (97% of total revenue). Notably, cost of sales worth AU$3.29b amounted to 91% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to AU$180.1m (59% of total expenses). Explore how PGC's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 5.2% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Healthcare industry in Australia.

Performance of the Australian Healthcare industry.

The company's shares are down 15% from a week ago.

Risk Analysis

We should say that we've discovered 1 warning sign for Paragon Care that you should be aware of before investing here.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.